【発明の名称】ベンジリデン-チアゾリジンジオン類およびアナログ類ならびに炎症の治療におけるその使用

Title:

【発明の名称】ベンジリデン-チアゾリジンジオン類およびアナログ類ならびに炎症の治療におけるその使用

Document Type and Number:

Japanese Patent JP2003531104

Kind Code:

A

Abstract:

The present invention relates to certain substituted heterocycles of Formula (I) which are useful in the treatment of diseases related to lipid and carbohydrate metabolism, such as type 2 diabetes, adipocyte differentiation, uncontrolled proliferation, such as lymphoma, Hodgkin's Disease, leukemia, breast cancer, prostate cancer or cancers in general; and inflammation, such as osteoarthritis, rheumatoid arthritis, Crohn's Disease or Inflammatory Bowel Disease.

More Like This:

JP2015017091	QUINONE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF
WO/2022/250466	PHARMACEUTICAL COMPOSITION FOR SUPPRESSING ENZALUTAMID RESISTANCE IN PROSTATE CANCER AND PHARMACEUTICAL COMPOSITION FOR TREATING PROSTATE CANCER HAVING ENZALUTAMID RESISTANCE
WO/2010/111436	ANTIVIRAL COMPOUNDS AND USES THEREOF

Inventors:

Magnus Fir
Catherine Tetidodian
Fushien A Al-Shama
Andrea Fanjul
David Pn Playnet
Lyle W Spruce

Application Number:

JP2001519690A

Publication Date:

October 21, 2003

Filing Date:

August 31, 2000

Export Citation:

Click for automatic bibliography generation Help

Assignee:

MAXIA PHARMACEUTICALS, INC.

International Classes:

A61K31/4166; A61K31/426; A61K31/4439; A61K31/4709; A61K31/498; A61P1/00; A61P1/04; A61P3/06; A61P3/08; A61P3/10; A61P9/10; A61P11/00; A61P15/00; A61P19/02; A61P29/00; C07D233/76; A61P35/00; A61P35/02; C07D233/40; C07D233/42; C07D233/86; C07D233/96; C07D261/12; C07D277/20; C07D277/34; C07D277/36; C07D401/06; C07D401/10; C07D403/10; C07D405/10; C07D417/06; C07D417/10; (IPC1-7): C07D277/34; A61K31/426; A61K31/4439; A61P1/04; A61P3/06; A61P3/08; A61P3/10; A61P9/10; A61P11/00; A61P15/00; A61P19/02; A61P29/00; A61P35/00; A61P35/02; C07D417/06

Attorney, Agent or Firm:

Aoyama Ryo (2 outside people)

Previous Patent: JP2003531103

Next Patent: 造影剤および治療薬として有用なコバラミン結合体